Photo by bermixstudio from unsplash
Nickel et al describe a single-arm trial using dose-escalated hydroxyurea and regular transfusions to prevent complications of sickle cell anemia. Preliminary results suggest that a reduction in volume of red… Click to show full abstract
Nickel et al describe a single-arm trial using dose-escalated hydroxyurea and regular transfusions to prevent complications of sickle cell anemia. Preliminary results suggest that a reduction in volume of red cell requirements may be achievable.
Keywords:
combination dose;
transfusion approach;
hydroxyurea transfusion;
blood;
dose escalated;
escalated hydroxyurea
Journal Title: Blood
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!